Local Institution

Rome 168

0 studies enrolling now · 10 studies all time

What they study most

Albuminuria, Bladder Cancer, Bladder Neoplasms, Chronic Hepatitis B, Chronic Myeloid Leukemia, Kidney Neoplasms, Melanoma, Multiple Myeloma, Neoplasm, Bladder, Newly Diagnosed, Previously Untreated Multiple Myeloma, Nonalcoholic Steatohepatitis (NASH), Prostate Cancer

Studies at this site

• Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting — Completed
• PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Previously Untreated Multiple Myeloma (ELO 1 Substudy) — Stopped early
• Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection — Completed
• Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma — Completed
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer — Completed
• Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria — Completed
• Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium — Completed